| Withdrawn | Safety, Tolerability and Immunogenicity of INO-4800 for COVID19 in Healthy Volunteers Coronavirus Infection | Phase 1 | 2022-10-01 |
| Completed | Safety, Tolerability and Immunogenicity of INO-4700 for MERS-CoV in Healthy Volunteers Middle East Respiratory Syndrome Coronavirus (MERS-CoV) | Phase 2 | 2021-06-21 |
| Completed | Dose-ranging Study: Safety, Tolerability and Immunogenicity of INO-4500 in Healthy Volunteers in Ghana Lassa Fever | Phase 1 | 2021-01-27 |
| Terminated | Safety, Immunogenicity, and Efficacy of INO-4800 for COVID-19 in Adults at High Risk of SARS-CoV-2 Exposure Coronavirus Infection, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), COVID-19 Disease | Phase 2 / Phase 3 | 2020-11-30 |
| Completed | INO-3107 With Electroporation (EP) in Participants With HPV-6- and/or HPV-11-Associated Recurrent Respiratory Respiratory Papillomatosis | Phase 1 / Phase 2 | 2020-10-07 |
| Completed | Safety, Tolerability and Immunogenicity of INO-4800 for COVID-19 in Healthy Volunteers Coronavirus Infection | Phase 1 | 2020-04-03 |
| Completed | Safety, Tolerability and Immunogenicity of INO-4500 in Healthy Volunteers Lassa Fever | Phase 1 | 2019-05-09 |
| Completed | REVEAL 2 Trial (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL) Cervical Dysplasia, Cervical High Grade Squamous Intraepithelial Lesion, HSIL | Phase 3 | 2019-02-28 |
| Active Not Recruiting | INO-5401 and INO-9012 Delivered by Electroporation (EP) in Combination With Cemiplimab (REGN2810) in Newly-Dia Glioblastoma | Phase 1 / Phase 2 | 2018-05-31 |
| Completed | INO-5401 + INO-9012 in Combination With Atezolizumab in Locally Advanced Unresectable or Metastatic/Recurrent Urothelial Carcinoma | Phase 1 / Phase 2 | 2018-05-24 |
| Completed | VGX-3100 Delivered Intramuscularly (IM) Followed by Electroporation (EP) for the Treatment of HPV-16 and/or HP Anal Neoplasm | Phase 2 | 2018-05-15 |
| Completed | Evaluation of VGX-3100 and Electroporation Alone or in Combination With Imiquimod for the Treatment of HPV-16 Vulvar High Grade Squamous Intraepithelial Lesion (HSIL), Vulvar Dysplasia, Vulvar Intraepithelial Neoplasia (VIN) | Phase 2 | 2017-08-31 |
| Completed | REVEAL 1 (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL) Cervical Dysplasia, Cervical High Grade Squamous Intraepithelial Lesion, HSIL | Phase 3 | 2017-06-28 |
| Completed | Trial to Evaluate Safety and Immunogenicity of INO-5150 Alone or With INO-9012 in Men With Prostate Cancer Prostate Cancer | Phase 1 | 2015-07-01 |
| Completed | Open-Label Study of INO-4212 With or Without INO-9012, Administered IM or ID Followed by Electroporation in He Ebola Vaccine | Phase 1 | 2015-05-01 |
| Completed | Phase I Study of INO-1800 With or Without INO-9112 + EP in Chronic Hepatitis B Subjects Hepatitis B | Phase 1 | 2015-01-12 |
| Completed | hTERT Immunotherapy Alone or in Combination With IL-12 DNA Followed by Electroporation in Adults With Solid Tu Breast Cancer, Lung Cancer, Pancreatic Cancer | Phase 1 | 2014-12-01 |
| Completed | Study of HPV Specific Immunotherapy in Participants With HPV Associated Head and Neck Squamous Cell Carcinoma Head and Neck Squamous Cell Cancer | Phase 1 / Phase 2 | 2014-08-13 |
| Completed | A Study of INO-3112 DNA Vaccine With Electroporation in Participants With Cervical Cancer Cervical Cancer | Phase 1 / Phase 2 | 2014-06-06 |
| Completed | Immunotherapy in Subjects With HPV-6 Associated Aerodigestive Precancerous Lesions and Malignancies Aerodigestive Precancerous Lesions and Malignancies | Phase 1 | 2014-05-01 |
| Completed | A Follow-On Study With an H5 Influenza Vaccine for Subjects Who Participated in Study FLU-001 Healthy | Phase 1 | 2011-05-01 |
| Completed | A Study of DNA Vaccine With Electroporation for the Prevention of Disease Caused by H1 and H5 Influenza Virus Healthy | Phase 1 | 2011-05-01 |
| Completed | A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade Cervical Intraepithelial Neoplasia | Phase 2 | 2011-04-01 |
| Completed | Study of PENNVAX™-B (Gag, Pol, Env) + Electroporation in HIV-1 Infected Adult Participants HIV-1 Infection, HIV Infections | Phase 1 | 2011-01-01 |
| Completed | Fourth Dose of Human Papillomavirus (HPV) DNA Plasmid (VGX-3100) + EP in Adult Females Previously Vaccinated W Human Papillomavirus (HPV) | Phase 1 | 2010-07-01 |
| Completed | Study of VGX-3400X, H5N1 Avian Influenza Virus DNA Plasmid + Electroporation in Healthy Adults Healthy | Phase 1 | 2010-06-01 |
| Completed | Phase I of Human Papillomavirus (HPV) DNA Plasmid (VGX-3100) + Electroporation for CIN 2 or 3 Papillomavirus Infections | Phase 1 | 2008-05-01 |
| Terminated | Medpulser Electroporation With Bleomycin Study to Treat Posterior Head and Neck Squamous Cell Carcinoma Head Neck Cancer | Phase 3 | 2004-11-01 |
| Terminated | Medpulser Electroporation With Bleomycin Study to Treat Anterior Head and Neck Squamous Cell Carcinoma Head and Neck Cancer | Phase 3 | 2004-06-01 |
| Completed | Study Using the MedPulser Electroporation System With Bleomycin to Treat Cutaneous and Subcutaneous Cancer Cancer | Phase 4 | 2004-02-01 |
| Completed | Study Using the Medpulser Electroporation System With Bleomycin to Treat Head and Neck Cancer Head and Neck Cancer | Phase 4 | 2004-01-01 |